J&J Issues Global Recall Of Cilest Birth Control Pills

Law360, New York (June 4, 2013, 5:37 PM EDT) -- Johnson & Johnson is recalling 32 million packages of birth control pills sold outside of the U.S. because the drug releases an active ingredient too slowly, the company said Tuesday, marking the latest in a string of callbacks for the drugmaker.

The voluntary recall includes 179 batches of the oral contraceptive Cilest in 43 countries. An ingredient "is releasing slower than is required by the defined product specification," according to Johnson & Johnson.

The company classified the risk to women as "very low," saying the issue...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.